No Vacillation on HPV Vaccination.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 29522737.
- Also identified by DOI 10.1016/j.cell.2018.02.045.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Evidence of the safety and protective benefits of human papillomavirus virus (HPV) vaccines as an anti-cancer measure is overwhelming. However, vaccine uptake varies widely across countries and falls short of levels needed to achieve population immunity. We highlight policy measures that would help ensure greater worldwide coverage and save lives.
Medical subject headings
- Alphapapillomavirus
- Papillomavirus Infections
- Papillomavirus Vaccines
- Uterine Cervical Neoplasms